MetLife Investment Management LLC Sells 830 Shares of Humana Inc. (NYSE:HUM)

MetLife Investment Management LLC cut its position in shares of Humana Inc. (NYSE:HUM) by 2.6% in the third quarter, Holdings Channel.com reports. The institutional investor owned 31,312 shares of the insurance provider’s stock after selling 830 shares during the period. MetLife Investment Management LLC’s holdings in Humana were worth $9,918,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in HUM. Swedbank AB bought a new position in shares of Humana during the 1st quarter valued at approximately $37,174,000. Atria Investments Inc grew its stake in shares of Humana by 14.5% in the 1st quarter. Atria Investments Inc now owns 5,329 shares of the insurance provider’s stock worth $1,848,000 after buying an additional 673 shares in the last quarter. Cetera Investment Advisers grew its stake in shares of Humana by 249.0% in the 1st quarter. Cetera Investment Advisers now owns 20,945 shares of the insurance provider’s stock worth $7,262,000 after buying an additional 14,944 shares in the last quarter. Cetera Advisors LLC increased its holdings in shares of Humana by 472.1% in the 1st quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock worth $3,501,000 after buying an additional 8,333 shares during the last quarter. Finally, Clear Rock Advisors LLC raised its position in shares of Humana by 4.0% during the 1st quarter. Clear Rock Advisors LLC now owns 5,131 shares of the insurance provider’s stock valued at $1,779,000 after buying an additional 199 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

HUM has been the topic of several analyst reports. UBS Group reduced their price objective on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. Royal Bank of Canada cut their target price on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and increased their price target for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research note on Thursday, October 3rd. Finally, Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price on the stock in a research note on Tuesday, October 8th. Twenty equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, Humana presently has an average rating of “Hold” and an average target price of $315.86.

Humana Price Performance

Shares of HUM opened at $296.68 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The company has a 50 day moving average price of $275.60 and a 200-day moving average price of $329.77. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $526.47. The stock has a market capitalization of $35.72 billion, a PE ratio of 26.28, a PEG ratio of 2.40 and a beta of 0.52.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Equities analysts predict that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.19%. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.